Hunan Dajiaweikang Pharmaceutical IndustryLtd Balance Sheet Health
Financial Health criteria checks 2/6
Hunan Dajiaweikang Pharmaceutical IndustryLtd has a total shareholder equity of CN¥1.8B and total debt of CN¥2.9B, which brings its debt-to-equity ratio to 158%. Its total assets and total liabilities are CN¥6.0B and CN¥4.2B respectively. Hunan Dajiaweikang Pharmaceutical IndustryLtd's EBIT is CN¥132.8M making its interest coverage ratio 2.1. It has cash and short-term investments of CN¥392.5M.
Key information
158.0%
Debt to equity ratio
CN¥2.90b
Debt
Interest coverage ratio | 2.1x |
Cash | CN¥392.53m |
Equity | CN¥1.83b |
Total liabilities | CN¥4.21b |
Total assets | CN¥6.05b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 301126's short term assets (CN¥3.7B) exceed its short term liabilities (CN¥2.9B).
Long Term Liabilities: 301126's short term assets (CN¥3.7B) exceed its long term liabilities (CN¥1.4B).
Debt to Equity History and Analysis
Debt Level: 301126's net debt to equity ratio (136.6%) is considered high.
Reducing Debt: 301126's debt to equity ratio has increased from 51.2% to 158% over the past 5 years.
Debt Coverage: 301126's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 301126's interest payments on its debt are not well covered by EBIT (2.1x coverage).